Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.


Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

“To have someone come in and say, ‘We’re not covering that drug now,’ it’s devastating.” Read about one #patientst.co/ZTtsTKS3jV

Retweeted by Marinus Pharma